Alphanosos

Associate

Alphanosos leverages its disruptive, Artificial Intelligence (AI) based, proprietary discovery process to elaborate and patent active Water Extracts of Complex Mixes of Edible Plants (WECMEPs) and develop human and animal therapeutic solutions with superior efficacy and reduced risks of side effects relative to traditional mono-compound approaches. We concentrate our discovery efforts on selective elimination of deleterious cells and micro-organisms, including their biofilms, with our genuine alternatives to antibiotics enabling definitive, global and sustainable answers to AMR and to microbial acute infection and silent infections triggering and sustaining inflammatory diseases. Besides, we are active in oncology through partnerships and we commercialize some of our discoveries as cosmetics ingredients (COSMOS certified), and soon, finished dermatological products for canine pyoderma and human dermatoses situations (eczema, acne, psoriasis, mycobacteriosis). We are actively looking for additional licensees of our products and partnerships to accelerate our development of antimicrobials and of additional therapeutic indications.